Delivery Order SPE2DB25D3012-SPE2DB25FWYVS
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $1,199.46. This firm fixed-price delivery order, which is set to be completed by July 30, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.40 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg capsules (100-count units) on July 30, 2025. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 31, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,211.15 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) under a firm fixed price contract type. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside competitive procurement. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $1,152.43, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,260,982 units of Dextroamphetamine ER 10 mg capsules in 100 count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025, to supply pharmaceutical products and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules in a quantity of 100 units, with a ceiling value of $2,008.80. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Dextroamphetamine SR Capsules 15mg, with a ceiling value of $7,992.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYVSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dextroamphetamine ER 10 mg capsules (100-count units) valued at $1,020.65. This firm fixed-price delivery order, which is expected to be completed by July 28, 2025, carries no set-aside designation and was competitively awarded. The product will be sourced from the contractor's Conshohocken, Pennsylvania facility. This award represents a routine pharmaceutical delivery under the Defense Logistics Agency's medical supply chain operations, supporting federal healthcare procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. As the prime contractor on this IDC, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including controlled substances, specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies. The contractor's portfolio of federal awards demonstrates consistent capability in meeting competitive procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/25/25 |